A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer.

导出 OA

翻译打印收藏纠错

作者： Susan,Dent ^[1] ; Dean,Fergusson ^[2] ; Olexiy,Aseyev ^[3] ; Carol,Stober ^[4] ; Gregory,Pond ^[2] ; Arif A,Awan ^[5] ; Sharon F,McGee ^[1] ; Terry L,Ng ^[1] ; Demetrios,Simos ^[1] ; Lisa,Vandermeer ^[6] ; Deanna,Saunders ^[2] ; John F,Hilton ^[2] ; Brian,Hutton ^[1] ; Mark,Clemons ^[2]

作者单位： Division of Medical Oncology, Department of Medicine, The Ottawa Hospital, The University of Ottawa, Ottawa, ON K1H 8L6, Canada. ^[1] Cancer Therapeutics Program, The Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada. ^[2] Clinical Epidemiology Program, The Ottawa Hospital Research Institute, The University of Ottawa, Ottawa, ON K1H 8L6, Canada. ^[3] Thunder Bay Regional Cancer Care Northwest, Thunder Bay Regional Health Sciences Centre, Thunder Bay, ON P7B 6V4, Canada. ^[4] Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada. ^[5] Stronach Regional Cancer Center, Southlake Regional Health Care Centre, Newmarket, ON L3Y 2P9, Canada. ^[6]

关键词 breast cancer cardiac monitoring trastuzumab

主题词乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);人类(Humans);每搏输出量(Stroke Volume);心室功能, 左(Ventricular Function, Left)

DOI 10.3390/curroncol28060427

PMID 34940066

发布时间 2024-04-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交